BMJ Group: Drug Approval Pathway Benefits Industry Over Patients, Argues Expert
May 15, 2026
May 15, 2026
LONDON, England, May 15 (TNSjou) -- BMJ Group issued the following news release about The BMJ:
* * *
New drug approval pathway benefits industry over patients, argues expert
Approval mechanisms must be grounded in patient need and population health
*
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today.
The . . .
* * *
New drug approval pathway benefits industry over patients, argues expert
Approval mechanisms must be grounded in patient need and population health
*
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and the NHS, argues an expert in The BMJ today.
The . . .